SIPBS - University of Strathclyde
  Strathclyde Institute of Pharmacy and Biomedical Sciences

main content

photo

Dr Katharine C. Carter

Senior Lecturer

HW 610

k.carter@strath.ac.uk

Tel : +44 (0)141 548 3823 (Ext. 3823)


Profile

awaiting profile

"Indication of efficacy of MTL004-NIV in a lung cancer model"
Morvus Technology Ltd

"Demonstration of a platform enabling delivery system for non invasive drug delivery to the lungs"
Scottish Enterprise Proof of Concept

"KALADRUG-R New tools for monitoring drug resistance and treatment response in visceral leishmaniasis in the Indian subcontinent (FP7 Health)"
EU

Publications

  • Emma McFarlane, Katharine C. Carter, Andrew N. McKenzie, Paul M. Kaye, Frank Brombacher and James Alexander (2011) Endogenous IL-13 plays a crucial role in liver granuloma maturation during Leishmania donovani infection, independent of IL-4Ra-responsive macrophages and neutrophils. Journal of Infectious Diseases 204, 36-43 [DOI: 10.1093/infdis/jir080 ]

  • McFarlane E, Perez C, Chamoy M, Allenbach C, Carter K.C. Alexander J, Tacchini-Cottier F. (2008) Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani.. Infection and Immunity 76, 523-541

  • Jones L.A., Anthony J.P., Henriquez F.L., Lyons R.E., Nickdel M.B., Carter K.C., Alexander J., Roberts C.W. (2008) Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors Immunology. Immunology 125, 59-69

  • Mann JF, Shakir E, Carter KC, Mullen AB, Alexander J, Ferro VA. (2009) Lipid vesicle size of an oral influenza vaccine vehicle influences the Th1/Th2 bias in the immune response and protection against infection. Vaccine 27, 3643-3649 [DOI: 10.1016/j.vaccine.2009.03.040]

  • Henriquez, F.L., Campbell, S.A., ROBERTS, C.W., Mullen, A.B., Burchmore R. and Carter, K.C. (2010) Vaccination with recombinant L. donovani gamma-glutamylcysteine synthetase fusion protein protects against Leishmania donovani infection. Journal of Parasitology 96, 929-936

Group

Postgraduate students

Fatima Al-gawhari: 'Development of vesicular drug formulations of the treatment of cancer' (started 2009)

Manal Alsaadi: 'The oral and pulmonary bioavailability of cisplatin from non-ionic surfactant vesicles' (started 2007)

Basma Mohamed Doro: 'Development of an oral vaccine against Leishmania donovani' (started 2010)

Dima Semaan: 'Treatment of Leishmania by amphotercin non ionic vesicals' (started 2010)

Craig Shaw: 'Studies on development of drug resistance in Leishmania donovani' (started 2010)